Mild Traumatic Brain Injury Clinical Trial
— CogMindOfficial title:
Home-Based, Online, Mindfulness and Cognitive Training for Soldiers and Veterans With TBI
Verified date | November 2020 |
Source | Posit Science Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a parallel arm, double-blind, randomized, controlled clinical trial to assess the safety and efficacy of an experimental software program designed to improve cognitive functions versus a computer-based software control. Both the study and the software being investigated meet the criteria of Non-Significant Risk.
Status | Completed |
Enrollment | 23 |
Est. completion date | September 14, 2020 |
Est. primary completion date | August 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Participants must be 18 years of age or older - Participants must have diagnosis of mild traumatic brain injury (mTBI) confirmed by Ohio State University TBI Identification Method-Short Form (OSU TBI-ID-SF) - Participants must have persistent cognitive dysfunction confirmed by an objective measure (Automated Neuropsychological Assessment Metrics (ANAM) TBI Battery with a score at least one standard deviation below the age-adjusted norm for a military sample) or a subjective measure (Ruff Neurobehavioral Inventory (RNBI) with a score of greater than 70 on any of the four cognitive scales (Attention, Memory, Language, Executive) - Participants must be at least six months out from their most recent traumatic brain injury (TBI), concussion, and/or blast exposure - Participant must be a fluent English speaker - Participants must score = 70 on the Wechsler Test of Adult Reading (WTAR) - Participants must have adequate sensorimotor capacity to perform the program, including visual capacity adequate to read from a computer screen at a normal viewing distance, auditory capacity adequate to understand normal speech, and motor capacity adequate to control a computer mouse Exclusion Criteria: - Participants with history of TBI with loss of consciousness for more than 24 hours or post-traumatic amnesia for more than 7 days - Participants with a history of penetrating head wounds - Participants who are in-patients - Participants with a diagnosis of an illness or condition with known cognitive consequences (e.g., schizophrenia, bipolar disorder, cancer, multiple sclerosis) - Participants with active suicidal ideation with specific plan and intent or suicide-related behaviors within 2 months of consent as measured by the Columbia-Suicide Severity Rating Scale (C-SSRS) - Participants showing signs of intoxication due to current substance abuse (including alcohol and/or illegal drugs) during any in person visit - Participants with clinically significant visual field deficits - Participants judged to be lacking effort - Participants with problems performing assessments or comprehending or following spoken instructions - Participants enrolled in a concurrent clinical trial involving an investigational pharmaceutical, nutraceutical, medical device, or behavioral treatment for TBI that could affect the outcome of this study - Participant with self-reported claustrophobia or physician-reported implanted devices (e.g. pacemakers, cochlear implants, aneurysm clips, etc.) and pregnant women will not be able to participate in MRI portion of study. |
Country | Name | City | State |
---|---|---|---|
United States | Veterans Affairs Connecticut Health Care System | West Haven | Connecticut |
Lead Sponsor | Collaborator |
---|---|
Posit Science Corporation | VA Connecticut Healthcare System |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in Neurobehavioral Symptoms | Between-group magnitude of change in sum score using the self-report measure, Neurobehavioral Symptoms Index (NSI). The scoring range is 0-88. Higher scores indicate more severe neurobehavioral symptoms. | At 3 months and at 6 months | |
Other | Change in PTSD Symptoms | Between-group magnitude of change in sum score using the self-report measure, PTSD Checklist (PCL-5). The scoring range is 0-80. Higher scores indicate more severe PTSD symptoms | At 3 months and at 6 months | |
Other | Change in Depressive Symptoms | Between-group magnitude of change in sum score using the self-report measure, Beck Depression Inventory (BDI-II). The scoring range is 0-63. Higher scores indicate more severe depressive symptoms. | At 3 months and at 6 months | |
Other | Change in Health-Related Quality of Life | Between-group magnitude of change in sum score using the self-report measure, Quality of Life after Brain Injury (QOLIBRI). The scoring range is 0-100. Lower scores indicate lower quality of life. | At 3 months and at 6 months | |
Other | Change in Executive Function Symptoms | Between-group magnitude of change in After total T-score using the self-report measure, Frontal Systems Behavior Scale (FrSBe). Raw scores are converted to age- and education-corrected T-scores. The mean T-score is 50, scores greater than 65 are considered clinically significant. | At 3 months and at 6 months | |
Other | Change in Cognitive Symptoms | Between-group magnitude of change in sum score using the self-report measure, Cognitive Failures Questionnaire (CFQ). The scoring range is 0-100. Higher scores indicate more severe cognitive symptoms. | At 3 months and at 6 months | |
Other | Change in Work/School Status | Change in total score using the self-report questionnaire about their work/school status. | At 3 months and at 6 months | |
Other | Change in Physical Activity | Change in total score based on weekly self-report dairy about physical activity during training period. | At 3 months | |
Other | Change in Diet | Change in total score based on weekly self-report dairy about diet during training period. | At 3 months | |
Other | Change in Social Activity | Change in total score based on weekly self-report dairy about social activity during training period. | At 3 months | |
Other | Change in Sleep | Change in total score based on weekly self-report dairy about sleep during training period. | At 3 months | |
Other | Change in Functional Abilities | Change in total score based on weekly self-report dairy about functional abilities during training period. | At 3 months | |
Primary | Changes in performance on global cognitive composite score | Change in performance on global cognitive composite score based on the average of all normalized assessment measures. | At 3 months and at 6 months | |
Secondary | Changes in performance on processing speed composite score | Change in performance on processing speed will be measured using the composite score created by averaging the z-scores of Pattern Comparison, Letter Comparison, and Digit Symbol Coding tasks. | At 3 months and at 6 months | |
Secondary | Changes in performance on memory composite score | Change in performance on memory will be measured using the composite score created by averaging the z-scores of N-Back task, Spatial Working Memory task, WAIS-IV Digit Span and Rey Auditory Verbal Learning Test (RAVLT). | At 3 months and at 6 months | |
Secondary | Changes in performance on executive function composite score | Change in performance on executive function will be measured using the composite score created by averaging the z-scores for the Trail Making, Flanker, and Stroop tasks. | At 3 months and at 6 months | |
Secondary | Change in functional performance | Between-group magnitude of change in sum time of all tasks in the Timed Instrumental Activities of Daily Living (TIADL). Higher scores indicate greater impairment in functional performance. | At 3 months and at 6 months | |
Secondary | Change in TBI functional status | Between-group magnitude of change in overall T-score using the self-report measure, Mayo-Portland Adaptability Inventory (MPAI-4). The overall T-score range is -38 to 106. Higher scores indicate more severe TBI functional status. | At 3 months and at 6 months | |
Secondary | Changes in brain function | Change in resting state functional connectivity will be measured by 12-minutes of resting state functional MRI. Participants will be instructed to keep their eyes open and maintain attention on a white fixation cross on a black screen. | At 3 months | |
Secondary | Changes in brain structure | Structural brain integrity will be measured with a high resolution 3D T1-weighted scan with good gray/white matter contrast and a complementary high-resolution T2-weighted anatomical scan. | At 3 months | |
Secondary | Changes in task-related brain activation | Change in functional connectivity and brain activation will be measured while performing N-Back Task. | At 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04372797 -
Standardized Instruments to Provide Diagnostic and Prognostic Information in Mild Traumatic Brain Injury (mTBI)
|
N/A | |
Completed |
NCT01903525 -
DHA For The Treatment of Pediatric Concussion Related to Sports Injury
|
Phase 1 | |
Completed |
NCT01847040 -
Deployment Related Mild Traumatic Brain Injury (mTBI)
|
||
Completed |
NCT03678077 -
Trends in Cohabitation Status, Academic Achievement and Socio-economic Indicators After Mild Traumatic Brain Injury
|
||
Recruiting |
NCT05682677 -
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
|
N/A | |
Terminated |
NCT03345550 -
OPTIMA-TBI Pilot Study
|
Phase 2 | |
Completed |
NCT05095012 -
RECOVER Clinical Pathway for Pediatric Concussion
|
N/A | |
Recruiting |
NCT05886400 -
The Effects of Environmental Distractions on SCAT6 Outcomes
|
N/A | |
Recruiting |
NCT05262361 -
Persistent Post-Concussion Symptoms With Convergence Insufficiency
|
N/A | |
Active, not recruiting |
NCT03892291 -
Objective Dual-task Turning Measures for Return-to-duty Assessments
|
||
Completed |
NCT03688984 -
Treatment of Insomnia for Adolescents With Mild Traumatic Brain Injury
|
N/A | |
Completed |
NCT02057081 -
Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI
|
N/A | |
Recruiting |
NCT06233851 -
t-BIOMAP : Prospective Paediatric Cohort Study of Blood Biomarkers in mTBI
|
||
Completed |
NCT02844946 -
One-Day Life Skills Workshop for Veterans With TBI, Pain and Psychopathology
|
N/A | |
Completed |
NCT04641767 -
BIOmarkers of TRAumatic Brain Injury Spain (BIOTRABIS)
|
||
Recruiting |
NCT06112093 -
Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
|
N/A | |
Recruiting |
NCT03819608 -
Neuromodulation and Neurorehabilitation for mTBI Plus PTSD
|
N/A | |
Withdrawn |
NCT00580918 -
Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients
|
||
Completed |
NCT03319966 -
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
|
||
Recruiting |
NCT03846830 -
Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation
|
N/A |